Akebia Therapeutics, Inc. Liquidation Value
AKBA
Other
Cash & Equivalents
$184.84M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $184.84M
Total Obligations: -$214.74M
$-29.89M
Per share: $-0.11
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $184.84M
AR: $47.03M
Total Obligations: -$214.74M
$17.14M
Per share: $0.06
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $184.84M
AR: $47.03M
Inventory: $15.61M
Total Obligations: -$214.74M
$32.75M
Per share: $0.12
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-29.89M | $-0.11 |
| Liquid Liquidation Value | $17.14M | $0.06 |
| Operating Liquidation Value | $32.75M | $0.12 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $184.84M |
| Accounts Receivable | $47.03M |
| Inventory | $15.61M |
| Current Liabilities | $162.94M |
| Long-term Debt | $48.25M |
| Op. Lease Liability | $3.55M |
| Finance Lease | N/A |
| Shares Outstanding | 265.4M |
Explore all 213 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $184.84M | $47.03M | $15.61M | $21.18M | $162.94M | $48.25M | $3.55M | N/A |
| 2025-09-30 | $166.44M | $66.22M | $18.64M | $10.09M | $133.38M | $47.64M | $4.94M | N/A |
| 2025-06-30 | $137.31M | $72.81M | $16.71M | $11.55M | $118.72M | $47.06M | $6.30M | N/A |
▼ Community Notes